In vitro diagnostic immunoblot assay for automated confirmation of Bordetella pertussis IgG and IgA antibodies. Enables rapid and reliable serological diagnosis of pertussis infection and immunity status in clinical laboratory settings.
Manufactured by
Viramed Biotech AG
Planegg, Germany
Based on 40 years of experience in European and American markets Viramed® develops, produces and sells In-Vitro-Diagnostic test kits. Through research and development, the ViraChip® microarray product group is continuously expanding. Viramed® focuses on the serological detection of autoantibodies and antibodies against infectious disease parameters like Borrelia, Yersinia, Treponema+VDRL, Helicobacter, Bordetella, SARS-CoV-2, EBV, CMV, Hepatitis E Virus, Parvovirus B19, Zika Virus, Dengue Virus and Chikungunya Virus and Toxoplasma. Software solutions, device design and manufacturing provide full automation for the ViraChip® technology in the diagnostic laboratory.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Gold Standard Diagnostics Frankfurt GmbH
Germany · 2 relevant products
Vircell S.L.
Spain · 8 relevant products
Institut Virion\Serion GmbH
Germany · 1 relevant product
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 93 closest product alternatives
Gold Standard Diagnostics Frankfurt GmbH · Germany
Serological test for detection of Bordetella pertussis-specific IgA antibodies and CatACT markers. Used for diagnosis and confirmation of pertussis infection in clinical laboratory settings. Enables rapid identification of acute or recent infection to guide appropriate patient management and infection control measures.
Vircell S.L. · Spain
A fully automated indirect chemiluminescent immunoassay (CLIA) in monotest format for the detection of Bordetella pertussis toxin IgG antibodies. The test is self-contained with all necessary reagents, calibrators, and controls included in the strip.
Institut Virion\Serion GmbH · Germany
In vitro diagnostic assays for detection of Bordetella pertussis antibodies. Designed for whooping cough diagnosis and serological confirmation.
90 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products